In particular, the hypersensitivity of ATM-mutated cancers to ATR inhibition (13–16) could be driven by over-lapping and redundant functions of ATM and ATR kinases, given that there are over 700 suggested ATM/ATR substrates harbouring S/T-Q motifs (25–27). The gene discussed is ATR; the disease is cancer.